Cardiff Oncology (NASDAQ:CRDF) Price Target Raised to $18.00
Cardiff Oncology (NASDAQ:CRDF – Free Report) had its price objective lifted by HC Wainwright from $17.00 to $18.00 in a research report report published on Friday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. Cardiff Oncology Trading Up 1.1% CRDF stock opened at $2.66 on Friday. The company has a market […]
Cardiff Oncology (NASDAQ:CRDF – Free Report) had its price objective lifted by HC Wainwright from $17.00 to $18.00 in a research report report published on Friday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. Cardiff Oncology Trading Up 1.1% CRDF stock opened at $2.66 on Friday. The company has a market […]
